APCC Virtual Flipbook - Flipbook - Page 10
DAY 5 - FRIDAY 16 OCTOBER 2020
07:00
Women in Urology
Session - Clinical Urology
We are excited to introduce our inaugural ‘Woman
in Urology’ event as part of the APCC 2020. Despite
increases in the number of women in urology
worldwide, women are still vastly underrepresented
in our specialty. In this session we hope to highlight
the importance of increased female representation in
urology, discuss the difficulties faced, the importance
of leadership, and lessons learned from these
outstanding surgeons to inspire all of those with an
interest in the future of urology regardless of gender.
We are delighted to have international speakers,
Professor Stacy Loeb and Professor Kirsten Greene,
and Australian speakers, Dr Caroline Dowling, Dr
Lydia Johns- Putra and Dr Renu Eapen.
Join us for this live, with the opportunity to ask
questions to this fantastic panel. Dr Briony Norris
and Dr Sandra Elmer will moderate this must attend
session.
07:00
Welcome to APCC’s ‘Women in Urology’
07:05
Women in Urology: From the Perspective of
Training in Australia and New Zealand
Dr Lydia Johns Putra - Ballarat Urology
07:20
Representation of Women at Conferences
and the Importance of Fellowship
Dr Renu Eapen - Peter MacCallum Cancer Centre
07:35
Women in Urology and Leveraging Social
Media
Prof Stacy Loeb - New York University School of
Medicine
07:50
Making the Next Step: Challenges Facing
Women Leaders in Urology
Dr Caroline Dowling - Eastern Health
08:05
Female Representation in Uro-oncology and
Senior Faculty Roles in the United States
Prof Kirsten Greene - UVA Health
08:20
Live Question and Answer - Moderated by Dr
Briony Norris and Dr Sandra Elmer
12:00
PSMA-PET - Diagnostics, Theranostics & An
Update on Australian studies
Session - Clinical Urology, Translational
Science
PSMA-PET presents the most exciting tool for the
diagnosis and treatment of prostate cancer in many
years. This session explores the cutting edge of
diagnostics and theranostics with the specialists at
the forefront. The first talk outlines the importance of
standardised reporting – why we get false positives
and false negatives and how to avoid inaccurate
results. A series of world-first papers emanating from
Australia are then discussed – from the staging of
metastatic disease (Pro-PSMA study) to the evaluation
of the cancer within the prostate (PRIMARY study),
to the futuristic treatment of prostate cancer using
Lutetium-PSMA for both advanced and localised
disease.
This session is proudly supported by